1. Home
  2. AGCO vs JAZZ Comparison

AGCO vs JAZZ Comparison

Compare AGCO & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGCO Corporation

AGCO

AGCO Corporation

HOLD

Current Price

$109.35

Market Cap

8.1B

Sector

Industrials

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$168.00

Market Cap

10.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGCO
JAZZ
Founded
1990
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
10.8B
IPO Year
1992
2007

Fundamental Metrics

Financial Performance
Metric
AGCO
JAZZ
Price
$109.35
$168.00
Analyst Decision
Hold
Strong Buy
Analyst Count
10
15
Target Price
$115.60
$199.20
AVG Volume (30 Days)
673.5K
1.6M
Earning Date
10-31-2025
11-05-2025
Dividend Yield
3.34%
N/A
EPS Growth
121.88
N/A
EPS
5.02
N/A
Revenue
$10,049,100,000.00
$4,157,832,999.00
Revenue This Year
N/A
$6.00
Revenue Next Year
$3.17
$6.84
P/E Ratio
$21.84
N/A
Revenue Growth
N/A
4.14
52 Week Low
$73.79
$95.49
52 Week High
$121.16
$182.99

Technical Indicators

Market Signals
Indicator
AGCO
JAZZ
Relative Strength Index (RSI) 57.81 58.23
Support Level $102.94 $161.00
Resistance Level $107.88 $168.69
Average True Range (ATR) 3.23 4.94
MACD 0.50 -1.97
Stochastic Oscillator 75.19 32.44

Price Performance

Historical Comparison
AGCO
JAZZ

About AGCO AGCO Corporation

Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: